TREK1 upregulation is an endogenous mechanism delaying cognitive decline in Alzheimer’s Disease
Swagata Ghatak(National Institute of Science Education and Research)
Cited by 0
Related Papers
Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection
|Nature Chemical Biology|2022|35
Single‐Cell Patch‐Clamp/Proteomics of Human Alzheimer's Disease iPSC‐Derived Excitatory Neurons Versus Isogenic Wild‐Type Controls Suggests Novel Causation and Therapeutic Targets
|Advanced Science|2024|23
Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3